Mardi 14 octobre 2025Tuesday 14 October 2025
Marchés ouvertsMarket opened
  • SIVC
    720
    3,60%
  • BOAB
    6 500
    1,33%
  • BOAC
    7 000
    0,00%
  • BOAM
    1 525
    1,33%
  • BOAN
    5 600
    1,82%
  • BOAS
    3 300
    3,13%
  • BNBC
    995
    -0,50%
  • BICC
    6 980
    1,16%
  • SDSC
    1 500
    -3,22%
  • BOABF
    7 245
    3,50%
  • CFAC
    875
    0,00%
  • CIEC
    1 900
    2,98%
  • CBIBF
    8 800
    2,33%
  • SEMC
    815
    -1,80%
  • ECOC
    7 000
    0,00%
  • ETIT
    18
    0,00%
  • FTSC
    1 845
    1,37%
  • SVOC
    2 395
    0,00%
  • NEIC
    660
    0,00%
  • NTLC
    7 740
    -0,06%
  • NSBC
    5 900
    0,00%
  • ONTBF
    2 280
    -0,43%
  • ORGT
    2 735
    6,21%
  • ORAC
    10 700
    0,05%
  • PALC
    6 795
    6,17%
  • SAFC
    1 300
    -2,62%
  • SPHC
    1 870
    -4,10%
  • ABJC
    1 295
    0,00%
  • STAC
    895
    0,00%
  • SGBC
    15 850
    1,34%
  • CABC
    1 010
    1,00%
  • SICC
    3 310
    -7,41%
  • STBC
    6 095
    0,00%
  • SMBC
    9 810
    -0,80%
  • SIBC
    5 300
    0,00%
  • SDCC
    4 700
    -0,94%
  • SOGC
    2 745
    2,81%
  • SLBC
    90 000
    0,00%
  • SNTS
    17 000
    0,00%
  • SCRC
    495
    3,13%
  • TTLC
    1 790
    2,29%
  • TTLS
    2 545
    5,82%
  • PRSC
    1 675
    -6,94%
  • UNLC
    5 000
    0,00%
  • UNXC
    600
    7,14%
  • SHEC
    815
    1,24%

BIONTECH: Obtaining by the pharmaceutical company of mixed financing of up to USD 110 million from the EUROPEAN INVESTMENT BANK and the EUROPEAN COMMISSION

Submitted by c.kossa on Tue, 14/10/2025 - 10:27

Obtaining by the pharmaceutical company of mixed financing of up to USD 110 million from the EUROPEAN INVESTMENT BANK and the EUROPEAN COMMISSION to support the development of its messenger RNA vaccine manufacturing plant in Kigali, Rwanda, according to the business press

Retour